Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros











Base de datos
Tipo de estudio
Intervalo de año de publicación
1.
BMJ Open Diabetes Res Care ; 12(4)2024 Jul 18.
Artículo en Inglés | MEDLINE | ID: mdl-39025793

RESUMEN

INTRODUCTION: Prolonged hyperglycemia in diabetes mellitus can result in the development of diabetic nephropathy (DN) and increase the susceptibility to kidney failure. Low-intensity pulsed ultrasound (LIPUS) is a non-invasive modality that has demonstrated effective tissue repair capabilities. The objective of this study was to showcase the reparative potential of LIPUS on renal injury at both animal and cellular levels, while also determining the optimal pulse length (PL). RESEARCH DESIGN AND METHODS: We established a rat model of DN, and subsequently subjected the rats' kidneys to ultrasound irradiation (PL=0.2 ms, 10 ms, 20 ms). Subsequently, we assessed the structural and functional changes in the kidneys. Additionally, we induced podocyte apoptosis and evaluated its occurrence following ultrasound irradiation. RESULTS: Following irradiation, DN rats exhibited improved mesangial expansion and basement membrane thickening. Uric acid expression increased while urinary microalbumin, podocalyxin in urine, blood urea nitrogen, and serum creatinine levels decreased (p<0.05). These results suggest that the optimal PL was 0.2 ms. Using the optimal PL further demonstrated the reparative effect of LIPUS on DN, it was found that LIPUS could reduce podococyte apoptosis and alleviate kidney injury. Metabolomics revealed differences in metabolites including octanoic acid and seven others and western blot results showed a significant decrease in key enzymes related to lipolysis (p<0.05). Additionally, after irradiating podocytes with different PLs, we observed suppressed apoptosis (p<0.05), confirming the optimal PL as 0.2 ms. CONCLUSIONS: LIPUS has been demonstrated to effectively restore renal structure and function in DN rats, with an optimal PL of 0.2 ms. The mechanism underlying the alleviation of DN by LIPUS is attributed to its ability to improve lipid metabolism disorder. These findings suggest that LIPUS may provide a novel perspective for future research in this field.


Asunto(s)
Apoptosis , Diabetes Mellitus Experimental , Nefropatías Diabéticas , Podocitos , Animales , Nefropatías Diabéticas/patología , Nefropatías Diabéticas/terapia , Ratas , Masculino , Diabetes Mellitus Experimental/complicaciones , Podocitos/efectos de la radiación , Podocitos/patología , Ratas Sprague-Dawley , Riñón/patología , Riñón/efectos de la radiación , Modelos Animales de Enfermedad , Ondas Ultrasónicas , Terapia por Ultrasonido/métodos
2.
J Ultrasound Med ; 43(8): 1449-1460, 2024 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-38654492

RESUMEN

OBJECTIVES: To investigate the effects of low-intensity pulsed ultrasound (LIPUS) on the proliferation, differentiation, and tumor necrosis factor-α (TNF-α)-induced lipolysis of 3T3-L1 cells, and to explore the feasibility of regulating the release of free fatty acids (FFA) to prevent lipotoxicity. METHODS: Different intensities (30, 60, 90, and 120 mW/cm2) of LIPUS were applied to 3T3-L1 preadipocytes for different durations (5, 10, 15, 20, 25, and 30 minutes). Appropriate parameters for subsequent experiments were selected by assessing cell viability. The effect of LIPUS on the proliferation and differentiation of 3T3-L1 cells was evaluated by microscope observation, flow cytometry, and lipid content determination. After treated with LIPUS and TNF-α (50 ng/mL), the degree of lipolysis was assessed by measuring the extracellular FFA content. Quantitative real-time polymerase chain reaction (qRT-PCR) was used to detect the mRNA expression of relevant genes. RESULTS: Different parameters of LIPUS significantly enhance the viability of 3T3-L1 cells (P < .05), with 20 minutes and 30 mW/cm2 as the most suitable settings. After LIPUS treatment, 3T3-L1 cell proliferation accelerated, apoptosis rate and G1 phase cell proportion decreased, the content of lipid droplets and TG was increased in differentiated cells, while FFA release decreased (P < .05). The expression of PCNA, PPARγ, C/EBPα, Perilipin A mRNA increased, and the expression of TNF-α, ATGL, HSL mRNA decreased (P < .05). CONCLUSIONS: LIPUS could promote the proliferation and differentiation of 3T3-L1 cells and inhibit TNF-α-induced lipolysis, indicating its potential as a therapy for mitigating lipotoxicity caused by decompensated adipocytes.


Asunto(s)
Células 3T3-L1 , Diferenciación Celular , Proliferación Celular , Ácidos Grasos no Esterificados , Ondas Ultrasónicas , Animales , Ratones , Proliferación Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Lipólisis/efectos de la radiación , Adipocitos/efectos de la radiación , Factor de Necrosis Tumoral alfa
3.
Medicine (Baltimore) ; 103(11): e37513, 2024 Mar 15.
Artículo en Inglés | MEDLINE | ID: mdl-38489728

RESUMEN

BACKGROUND: While papillary thyroid carcinoma (PTC) generally exhibits a favorable prognosis post-surgery, the poorly differentiated subtype presents elevated rates of postoperative recurrence. Certain aggressive cases demonstrate invasive behavior, compromising adjacent structures and leading to a poor prognosis. This study delineates a unique case of postoperative PTC recurrence, complicated by esophageal fistula, that showed favorable outcomes following brief Vemurafenib treatment. PATIENT DESCRIPTION: A 64-year-old female patient underwent surgical resection for PTC, subsequently experiencing rapid tumor recurrence and development of an esophageal fistula. DIAGNOSIS: The patient was confirmed to have locally advanced PTC through intraoperative cytopathology. The cancer recurred postoperatively, culminating in the formation of an esophageal fistula. METHODS: The patient was administered Vemurafenib at a dosage of 960 mg twice daily following tumor recurrence. RESULTS: A 12-month regimen of targeted Vemurafenib therapy led to a substantial reduction in tumor size. Concurrently, the esophageal fistula underwent complete healing, facilitating successful removal of the gastrostomy tube. The tumor response was classified as stable disease. CONCLUSION SUBSECTIONS: Vemurafenib demonstrates potential as a targeted therapeutic strategy for recurrent PTC harboring the BRAFV600E mutation. This approach may effectively mitigate tumor dimensions and the associated risk of esophageal and tracheal fistulas.


Asunto(s)
Carcinoma Papilar , Carcinoma , Fístula Esofágica , Neoplasias de la Tiroides , Femenino , Humanos , Persona de Mediana Edad , Cáncer Papilar Tiroideo , Vemurafenib/uso terapéutico , Neoplasias de la Tiroides/complicaciones , Neoplasias de la Tiroides/tratamiento farmacológico , Neoplasias de la Tiroides/cirugía , Carcinoma/tratamiento farmacológico , Carcinoma/cirugía , Carcinoma/genética , Carcinoma Papilar/tratamiento farmacológico , Carcinoma Papilar/cirugía , Carcinoma Papilar/patología , Recurrencia Local de Neoplasia/patología , Pronóstico
4.
J Agric Food Chem ; 71(30): 11534-11543, 2023 Aug 02.
Artículo en Inglés | MEDLINE | ID: mdl-37463315

RESUMEN

Bisabolene is a bioactive sesquiterpene with a wide range of applications in food, cosmetics, medicine, and aviation fuels. Microbial production offers a green, efficient, and sustainable alternative. In this study, we focused on improving the titers of α-bisabolene in Yarrowia lipolytica by applying two strategies, (i) optimizing the metabolic flux of α-bisabolene biosynthetic pathway and (ii) sequestering α-bisabolene in lipid droplet, thus alleviating its inherent toxicity to host cells. We showed that overexpression of DGA1 and OLE1 to increase lipid content and unsaturated fatty acid levels was essential for boosting the α-bisabolene synthesis when supplemented with auxiliary carbon sources. The final engineered strain Po1gαB10 produced 1954.3 mg/L α-bisabolene from the waste cooking oil under shake flask fermentation, which was 96-fold higher than the control strain Po1gαB0. At the time of writing, our study represents the highest reported α-bisabolene titer in the engineered Y. lipolytica cell factory. This work describes novel strategies to improve the bioproduction of α-bisabolene that potentially may be applicable for other high-value terpene products.


Asunto(s)
Sesquiterpenos , Yarrowia , Yarrowia/genética , Yarrowia/metabolismo , Ingeniería Metabólica , Gotas Lipídicas/metabolismo , Terpenos/metabolismo , Sesquiterpenos/metabolismo
5.
Bioinformatics ; 33(14): 2078-2081, 2017 Jul 15.
Artículo en Inglés | MEDLINE | ID: mdl-28334342

RESUMEN

MOTIVATION: Effective tagging single-nucleotide polymorphism (SNP)-set selection is crucial to SNP-set analysis in genome-wide association studies (GWAS). Most of the existing tagging SNP-set selection methods cannot make full use of the information hidden in common or rare variants associated diseases. It is noticed that some SNPs have overlapping genetic information owing to linkage disequilibrium (LD) structure between SNPs. Therefore, when testing the association between SNPs and disease susceptibility, it is sufficient to elect the representative SNPs (called tag SNP-set or tagSNP-set) with maximum information. RESULTS: It is proposed a new tagSNP-set selection method based on LD information between SNPs, namely TagSNP-Set with Maximum Information. Compared with classical SNP-set analytical method, our method not only has higher power, but also can minimize the number of selected tagSNPs and maximize the information provided by selected tagSNPs with less genotyping cost and lower time complexity. CONTACT: hesicheng12@163.com. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.


Asunto(s)
Algoritmos , Genoma Humano , Estudio de Asociación del Genoma Completo/métodos , Desequilibrio de Ligamiento , Polimorfismo de Nucleótido Simple , Simulación por Computador , Predisposición Genética a la Enfermedad , Genómica/métodos , Humanos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA